Shareholding for the Period Ended September 30, 2016
Zydus Wellness Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click here07-10-2016
Shareholding for the Period Ended September 30, 2016
Zydus Wellness Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click hereBoard Meeting Intimation for Results & Closure of Trading Window
Zydus Wellness Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on October 25, 2016, to consider apart from other agenda items to approve the unaudited financial results for the quarter / half year ended on September 30, 2016.Further, as per code of conduct for prevention of Insider Trading adopted by the Company under SEBI [Prohibition of Insider Trading] Regulations, 2015, the Trading Window will...Zydus to market immunosuppressant drug of Switzerland's Neovii in India
The company has inked in-licensing pact with Swiss firm for the launches Grafalon, an immunosuppressant extensively used in solid organ transplants and stem cell transplantZydus partners Takeda to develop, market vaccine for chikungunya
The broad-based agreement between Zydus and Takeda includes early-stage development to the final commercialisation of the vaccine for chikungunyaZydus acquires derma brand Melgain from Issar Pharma
The brand will be marketed by Liva Healthcare, the group's division catering to dermatological segmentOutcome of AGM
Zydus Wellness Ltd has submitted to BSE a copy of the proceedings of the 22nd Annual General Meeting (AGM) of the Company held on August 03, 2016.Results of E-Voting and Poll of AGM
Zydus Wellness Ltd has informed BSE regarding announcement of the consolidated Results of E-Voting and Poll conducted at the Twenty Second Annual General Meeting of the Company held on August 03, 2016.Zydus Wellness Q1 profit up 20.12% at Rs23.46 crore
Consolidated total income of Zydus Wellness rises to `108.78 crore in June quarter as against `96.82 crore in the year ago periodStandalone & Consolidated Financial Results, Limited Review Report, Results Press Release for June 30, 2016
Zydus Wellness Ltd has informed BSE about : 1. Standalone Financial Results for the period ended June 30, 20162. Consolidated Financial Results for the period ended June 30, 20163. Standalone Limited Review for the period ended June 30, 20164. Consolidated Limited Review for the period ended June 30, 20165. Result Press Release for the period ended June 30, 2016Schedule of Analyst/Institutional Investors' meet
Zydus Wellness Ltd has informed BSE that the Company has planned investor interaction through a conference call on August 02, 2016 at 4:00 p.m. post announcement of unaudited financial results for the quarter ended on June 30, 2016.The details of the conference call is uploaded on the website of the Company.